The amylin analogs and combination therapies competitive landscape report delivers important insights into approved as well as ongoing research of 20+ pipeline amylin analogs and combination therapies ...
Yarrow Bioscience, Inc. ("Yarrow" or the "Company") , a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, today announced the ...
MAYOR of Kingston Andrew Swaby is one of the 46 mayors from 15 countries selected for the 10th class of the Bloomberg Harvard ...
Antioch Mayor Ron Bernal (left, second row) and his classmates were joined by Michael Bloomberg (front, center) on the second day of the Bloomberg Harvard City Leadership Initiati ...
Title: First-in-Class Clinical Stage Deoxycytidine Kinase Inhibitor Improves Visual Acuity in Multiple Mouse Models of Optic Neuritis Authors: Peter M. Clark, PhD; Kenneth A. Schultz, MD; KM Ryan, BS ...
Revenue of $103.7 million exceeded expectations, marking a 17% YoY growth. EPS missed the forecast by 16.28%, reported at -$0.50. Gross margin improved to 52%, up 4 percentage points YoY. Stock price ...
NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE”) and Yarrow Bioscience, Inc. (“Yarrow”) today announced that they have entered into a definitive merger ...
Neurodegenerative diseases like Alzheimer's, Parkinson's, and Huntington's disease are characterized by the progressive loss of neurons. The resulting debilitating symptoms, such as loss of memory and ...
Build a purposeful career translating science into business innovation. This programme empowers students to create new social and economic value from bioscience research ideas, by learning the skills ...
This programme will help you understand how to develop research from the lab to the clinic. With a bioscience background you will develop your scientific knowledge base whilst improving your ability ...
Global trade uncertainty and evolving tariff policies are shifting how bioscience companies view their supply chains. What once seemed like stable offshore manufacturing arrangements now carry myriad ...